NI Pharmacist Suspended for 12 Months After Supplying Paroxetine Without Prescription and Inappropriate Concurrent Antidepressant Dispensing via MDS
Date of Decision: July 23, 2013
Registrant's Role: Pharmacist
Allegations:
- On various dates between 4 June 2010 and 8 April 2011, at a community pharmacy in Dromore, County Down, the registrant caused, allowed or permitted the supply of the prescription only medicine (POM) Paroxetine to Patient B without a valid prescription, in contravention of sections 58(2)(a) and 67(2) of the Medicines Act 1968.
- On various dates within the same period, the registrant caused, allowed or permitted the concurrent supply of two antidepressant POMs—Paroxetine and Venlafaxine—to Patient B within a Monitored Dosage System (MDS) cassette, despite Paroxetine having been discontinued. He did so:
- Without properly communicating with the prescribing General Practitioner;
- Without properly considering the clinical appropriateness of concurrent therapy;
- Without raising appropriate concerns regarding the clinical suitability of the combination; and
- Without proper regard for the patient’s welfare.
- On various dates between 4 June 2010 and 8 April 2011, the registrant dispensed unknown POMs to at least 15 patients via an MDS system without valid prescriptions, in circumstances corresponding to retail sale, contrary to sections 58(2)(a) and 67(2) of the Medicines Act 1968.
- The registrant failed to:
- Promptly engage with an investigation conducted by the Health and Social Care Board;
- Properly engage with that investigation;
- Recognise deficiencies in internal pharmacy procedures or practice; and
- Follow standard operating procedures (SOPs).
Outcome: Suspension from the Register for 12 months
GPhC Standards Breached:
- Principle 1 – Make the safety and welfare of patients your prime concern
- Principle 4 – Exercise professional judgement in the interests of patients and the public
- Principle 6 – Maintain and develop professional knowledge and competence
- Principle 7 – Act with honesty and integrity
- Principle 8 – Provide a high standard of practice and care at all times
Case Summary
Allegations
This case concerned serious and prolonged failures in the dispensing and supply of prescription-only medicines (POMs) within a community pharmacy setting. The registrant, a pharmacist and pharmacy owner, was found to have supplied Paroxetine—a selective serotonin reuptake inhibitor (SSRI)—to Patient B without a valid prescription over a period of approximately 10 months.
Paroxetine is a POM indicated for major depressive disorder, anxiety disorders, obsessive-compulsive disorder, and other psychiatric conditions. As with all SSRIs, it carries known risks including serotonin syndrome, withdrawal phenomena, and drug interactions. Its supply without appropriate prescribing oversight represents a significant breach of Medicines Act requirements and undermines core safeguards in medicines governance.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Note: The original PDF document is not available for this case.